$42.5 MILLION SETTLEMENT WITH ALPHARMA OVER KICKBACKS
Alpharma Inc. has agreed to pay $42.5 million to settle a False Claims Act case charging the company with kickbacks in connection with the sale of morphine-based drug, Kadian. The drug company also misrepresented the safety and efficacy of the drug . Though a settlement has been reached, HHS has expressly reserved the right “to institute, direct, or to maintain any administrative action seeking exclusion against Alpharma and/or King, and/or their officers, directors, and employees, from Medicare, Medicaid, and all other Federal health care programs.”